Yilei Mao Selected Research

Yilei Mao Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 03/2008
38	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2009
9	Cholangiocarcinoma 01/2024 - 01/2016
7	Inflammation (Inflammations) 01/2024 - 08/2011
7	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2011
6	Liver Neoplasms (Liver Cancer) 03/2024 - 12/2010
6	Liver Failure 01/2021 - 04/2015
6	Fibrosis (Cirrhosis) 01/2020 - 12/2010
5	Hypertension (High Blood Pressure) 08/2022 - 01/2020
5	Liver Diseases (Liver Disease) 01/2021 - 05/2011
4	Carcinogenesis 03/2024 - 09/2010
4	Carcinoma (Carcinomatosis) 01/2022 - 08/2020
4	Hepatitis 01/2020 - 01/2016
3	Ascites 01/2024 - 04/2015
3	Fatigue 08/2022 - 08/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2011
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 10/2019
2	Body Weight (Weight, Body) 01/2023 - 01/2019
2	Gallbladder Neoplasms (Gallbladder Cancer) 08/2022 - 01/2021
2	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 02/2013
2	Jaundice (Icterus) 01/2021 - 01/2020
2	Disease Progression 01/2021 - 01/2020
2	Fatty Liver 01/2020 - 01/2019
2	Hepatitis B 04/2016 - 04/2015
1	Microsatellite Instability 01/2024
1	Portal Hypertension 07/2023
1	Flatulence 03/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Necrosis 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Whooping Cough (Pertussis) 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2010
11	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2010
8	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
8	lenvatinibIBA 06/2023 - 06/2018
7	AntigensIBA 01/2022 - 01/2020
6	RNA (Ribonucleic Acid)IBA 09/2022 - 10/2019
5	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 09/2010
5	CarbohydratesIBA 01/2022 - 01/2020
4	BilirubinIBA 08/2022 - 04/2015
4	AlbuminsIBA 01/2021 - 01/2016
4	Fetal Proteins (Fetoprotein)IBA 01/2021 - 06/2012
3	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 06/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2016
3	LipidsIBA 01/2022 - 08/2013
3	Cell-Free Nucleic AcidsIBA 01/2021 - 04/2015
2	Biocompatible Materials (Biomaterials)IBA 06/2023 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2021
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022 - 12/2010
2	AntibodiesIBA 08/2022 - 08/2021
2	baysilon (polydimethylsiloxane)IBA 01/2022 - 11/2020
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
2	Transaminases (Aminotransferases)IBA 08/2021 - 08/2020
2	GlypicansIBA 07/2021 - 03/2014
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 04/2016
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2016
2	EnzymesIBA 01/2020 - 01/2016
2	LigandsIBA 01/2019 - 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024
1	TensinsIBA 03/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	GalactosamineIBA 01/2024
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2024
1	LipopolysaccharidesIBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	Contrast MediaIBA 07/2023
1	entecavir FDA Link 02/2023
1	Tenofovir (Viread)FDA Link 02/2023
1	regorafenibIBA 01/2023
1	cabozantinibIBA 01/2023
1	Sunitinib (Sutent)FDA Link 11/2022
1	YttriumIBA 06/2022
1	HU 211 (HU 210)IBA 01/2022
1	NitrogenIBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	Leptin ReceptorsIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	lonidamineIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	rottlerinIBA 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	MART-1 AntigenIBA 07/2021
1	Inhibins (Inhibin)IBA 07/2021
1	SynaptophysinIBA 07/2021

Therapy/Procedure

18	Therapeutics 06/2023 - 02/2013
12	Hepatectomy 09/2020 - 11/2009
8	Immunotherapy 01/2024 - 01/2019
3	Length of Stay 01/2024 - 04/2021
3	Transplantation 01/2021 - 03/2012
2	Drug Therapy (Chemotherapy) 11/2023 - 02/2013
2	Radiotherapy 06/2022 - 02/2013
1	Microbubbles 07/2023
1	Operative Surgical Procedures 03/2023
1	Microspheres (Microsphere) 06/2022